share_log

ELITE PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities-Director Caskey Davis S

SEC ·  Jul 2, 2021 06:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more